HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nancy Abd-Elkader Hagras Selected Research

Spiramycin

3/2022Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.
1/2022The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.
9/2019Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nancy Abd-Elkader Hagras Research Topics

Disease

4Toxoplasmosis
04/2022 - 09/2019
1Schistosomiasis mansoni
01/2021

Drug/Important Bio-Agent (IBA)

3ChitosanIBA
03/2022 - 09/2019
3SpiramycinIBA
03/2022 - 09/2019
1Sulfadiazine (Sulphadiazine)FDA Link
04/2022
1AlginatesIBA
01/2022
1Propolis (Bee Bread)IBA
01/2022
1Praziquantel (Biltricide)FDA Link
01/2021